Literature DB >> 2820070

Indications for surgical treatment in small cell carcinoma of the lung.

J A Meyer.   

Abstract

Small cell carcinoma of the lung is notable for extreme malignancy in clinical behavior, with rapid growth, wide dissemination, and short survival after treatment. It is highly responsive to chemotherapy and radiation therapy, yet seldom cured. Prevalent therapeutic dogma rules out surgical resection as any part of treatment. We find, however, that patients with disease in stages I and II, treated with initial resection followed by the full course of chemotherapy, have a good prognosis for long disease-free survival.

Entities:  

Mesh:

Year:  1987        PMID: 2820070     DOI: 10.1016/s0039-6109(16)44348-3

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  3 in total

1.  Is the progress in cancer treatment results adequate or are we confronted with a more or less worldwide stagnation.

Authors:  K Karrer
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC).

Authors:  K Karrer; H Denck; H Karnicka-Mlodkowska; P Drings; J Orel; G M Salzer; M Thermann; A Lattuneddu; Y Sun; E Hata
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Long term survival after pulmonary resection for small cell carcinoma of the lung.

Authors:  U S Prasad; A R Naylor; W S Walker; D Lamb; E W Cameron; P R Walbaum
Journal:  Thorax       Date:  1989-10       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.